Compare, Analyse AJANTA PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AJANTA PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
AJANTA PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,422352-   
Low Rs898254-   
Sales per share (Unadj.) Rs233.5104.6-  
Earnings per share (Unadj.) Rs44.0-26.4-  
Cash flow per share (Unadj.) Rs52.2-21.8-  
Dividends per share (Unadj.) Rs9.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs255.182.1-  
Shares outstanding (eoy) m88.02168.78-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.02.9 171.7%   
Avg P/E ratio x26.4-11.5 -229.7%  
P/CF ratio (eoy) x22.2-13.9 -160.5%  
Price / Book Value ratio x4.53.7 123.3%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m102,08151,080 199.8%   
No. of employees `0006.84.3 158.4%   
Total wages/salary Rs m4,3073,206 134.4%   
Avg. sales/employee Rs Th3,022.64,112.3 73.5%   
Avg. wages/employee Rs Th633.4746.8 84.8%   
Avg. net profit/employee Rs Th569.1-1,036.2 -54.9%   
INCOME DATA
Net Sales Rs m20,55417,654 116.4%  
Other income Rs m211124 170.5%   
Total revenues Rs m20,76517,778 116.8%   
Gross profit Rs m5,664-3,059 -185.1%  
Depreciation Rs m721762 94.6%   
Interest Rs m12478 2.4%   
Profit before tax Rs m5,143-4,176 -123.2%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,273261 487.9%   
Profit after tax Rs m3,870-4,448 -87.0%  
Gross profit margin %27.6-17.3 -159.0%  
Effective tax rate %24.8-6.2 -396.1%   
Net profit margin %18.8-25.2 -74.7%  
BALANCE SHEET DATA
Current assets Rs m11,81212,930 91.4%   
Current liabilities Rs m3,7767,275 51.9%   
Net working cap to sales %39.132.0 122.1%  
Current ratio x3.11.8 176.0%  
Inventory Days Days77111 69.8%  
Debtors Days Days82124 65.8%  
Net fixed assets Rs m14,3987,537 191.0%   
Share capital Rs m17582 214.0%   
"Free" reserves Rs m22,2770-   
Net worth Rs m22,45213,856 162.0%   
Long term debt Rs m74,869 0.1%   
Total assets Rs m26,96226,176 103.0%  
Interest coverage x444.3-7.7 -5,746.5%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x0.80.7 113.0%   
Return on assets %14.4-15.2 -94.9%  
Return on equity %17.2-32.1 -53.7%  
Return on capital %23.0-19.8 -115.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m8,5800-   
CASH FLOW
From Operations Rs m3,7481,507 248.7%  
From Investments Rs m-2,228-463 481.5%  
From Financial Activity Rs m-1,4754,419 -33.4%  
Net Cashflow Rs m455,464 0.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.85 Rs / ZAR

Compare AJANTA PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare AJANTA PHARMA With: CADILA HEALTHCARE  WOCKHARDT  SHASUN PHARMA  ALEMBIC LTD  ELDER PHARMA  



Today's Market

September Quarter Results, IPO Buzz, and Top Stocks in Action Today(Pre-Open)

On Wednesday, Indian share markets traded rangebound throughout the day and ended marginally higher. The BSE Sensex closed higher by 95 points to end above 39,000-mark.

Related Views On News

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 8.4% YoY). Sales on the other hand came in at Rs 6 bn (up 19.8% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

AJANTA PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 5.9% (Quarterly Result Update)

May 3, 2019 | Updated on May 3, 2019

For the quarter ended March 2019, AJANTA PHARMA has posted a net profit of Rs 889 m (down 5.9% YoY). Sales on the other hand came in at Rs 5 bn (down 2.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

My Top 10 Stocks for Accelerated Profits

Oct 18, 2019

Equitymaster's co-head of research and editor of Microcap Millionaires, Rahul Shah, talks to us about his market-beating system and his 10 best stocks to buy now. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Oct 23, 2019 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS